Multidisciplinary

Top Medical News
2 hours ago
Pregnant women who receive an opioid prescription tend to experience new persistent opioid use, results of a study have shown.
2 hours ago
No baseline clinical factor is predictive of treatment success in women receiving medical management with misoprostol for early pregnancy loss, according to a study. However, the addition of mifepristone seems to improve treatment success.
4 hours ago
The novel coronavirus disease (COVID-19) presents as a severe disease in most of the older patients and carries distinctive features, such as multiorgan injury and confusion and delirium, a new study reports.
5 hours ago
In patients with COVID-19, use of N-acetylcysteine at high doses does not seem to prevent respiratory failure among those patients with severe disease, as shown in a study.
7 hours ago
Neonatal abstinence syndrome leads to several adverse childhood outcomes, such as mental health problems, poor school performance, and maltreatment, reports a new meta-analysis.
Roshini Claire Anthony, 19 hours ago

Women with incident, proliferative benign breast diseases (BBDs) may have an elevated risk of developing breast cancer, according to a retrospective study conducted in Spain.

19 hours ago
Disc haemorrhage is a relatively common presentation that leads to the referral to a glaucoma clinic, a recent study has found.
Special Reports
26 Oct 2020

An estimated 463 million adults – about one in 11 – had diabetes in 2019. These numbers are expected to rise to 700 million by 2045. Worse, one in two people are undiagnosed. [https://www.idf.org/, accessed 19 October 2020]

Pearl Toh, 22 Oct 2020
The combination therapy comprising carfilzomib, cyclophosphamide and dexamethasone (KCd) is effective, with a tolerable safety profile, in an Asian cohort with high-risk multiple myeloma (MM) — thus providing a more economical alternative as a potential upfront regimen in resource-limited settings, according to leading experts during a myeloma education webinar.
16 Oct 2020
Antihistamines (AHs) are the mainstay of treatment for allergic rhinitis (AR) in primary care. Nevertheless, choosing the best therapy from a wide selection of AHs can be challenging. At a virtual forum hosted by Bayer Co. (Malaysia), two experts discussed the role of patient profiling as a tool to guide the choice of AHs for AR.
Audrey Abella, 14 Oct 2020
Despite a 90-percent cure rate after first treatment for children with acute lymphoblastic leukaemia (ALL), approximately 10–15 percent of patients with paediatric ALL will experience relapse. [Expert Rev Anticancer Ther 2017;17:725-736] A recent webinar on the current landscape of ALL highlighted the potential of immunotherapy for paediatric patients with relapsed or refractory ALL, thus providing hope for this high-risk patient group.
Pearl Toh, 21 Sep 2020
Early and sustained treatments with simplified regimen are the key to achieving good asthma control, said experts during a presentation at the ERS 2020 Congress.
Pearl Toh, 16 Sep 2020
Mepolizumab, a first-in-class anti-IL-5* antibody, effectively prevents asthma exacerbations in patients with severe eosinophilic asthma (SEA), according to a presentation at the ERS 2020 Congress.
16 Sep 2020
XOFLUZA – Baloxavir marboxil 20 mg and 40 mg FC tab
Conference Reports
Roshini Claire Anthony, 30 Oct 2020

Women with incident, proliferative benign breast diseases (BBDs) may have an elevated risk of developing breast cancer, according to a retrospective study conducted in Spain.

Pearl Toh, 29 Oct 2020
Adding nivolumab to chemotherapy in the first-line setting significantly improves survival compared with chemotherapy alone in patients with HER2-negative advanced gastric/gastroesophageal (G/GEJ) cancer or oesophageal adenocarcinoma (EAC), shows the CheckMate 649 study presented at ESMO 2020.
Pearl Toh, 27 Oct 2020
Olaparib, a PARP* inhibitor used to treat ovarian and breast cancer, also extends overall survival (OS) of men with metastatic castration-resistant prostate cancer (mCRPC) harbouring at least one mutation in BRCA1, BRCA2, or ATM, according to final report of the PROfound** study presented at ESMO 2020.
Elaine Soliven, 27 Oct 2020
Ultra rapid lispro (URLi) was noninferior to lispro in reducing HbA1c levels in adults with type 1 diabetes (T1D), according to the PRONTO-Pump-2* study presented at EASD 2020.
Roshini Claire Anthony, 23 Oct 2020

Durvalumab with or without tremelimumab in the first-line setting does not improve overall survival (OS) over standard-of-care (SoC) chemotherapy in patients with unresectable, locally advanced or metastatic urothelial carcinoma, according to the phase III DANUBE trial.

Roshini Claire Anthony, 21 Oct 2020

NT-814, an oral, non-hormonal dual neurokinin 1,3 receptor antagonist may reduce the frequency of hot flashes, while improving quality of life (QoL) and sleep in postmenopausal women, according to results of the phase IIb SWITCH-1 trial presented at NAMS 2020.

Roshini Claire Anthony, 20 Oct 2020

The increased risk of mortality among patients with cancer diagnosed with COVID-19 may be due to their older age and presence of comorbidities, according to a study presented at ECCVID 2020.

CME Modules
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download